Drug Shortage Report for DILAUDID
| Report ID | 155193 |
| Drug Identification Number | 00125083 |
| Brand name | DILAUDID |
| Common or Proper name | Hydromorphone hydrochloride |
| Company Name | PURDUE PHARMA |
| Market Status | MARKETED |
| Active Ingredient(s) | HYDROMORPHONE HYDROCHLORIDE |
| Strength(s) | 2MG |
| Dosage form(s) | TABLET |
| Route of administration | ORAL ORAL |
| Packaging size | 100 |
| ATC code | N02AA |
| ATC description | OPIOIDS |
| Reason for shortage | Delay in shipping of the drug. |
| Anticipated start date | 2022-02-17 |
| Actual start date | 2022-02-17 |
| Estimated end date | 2022-03-04 |
| Actual end date | 2022-03-01 |
| Shortage status | Resolved |
| Updated date | 2022-03-02 |
| Company comments | |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 3381 STEELES AVENUE EAST TORONTO, ONTARIO CANADA M2H 3S7 |
| Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v8 | 2022-03-02 | English | Compare |
| v7 | 2022-03-01 | French | Compare |
| v6 | 2022-03-01 | English | Compare |
| v5 | 2022-02-25 | French | Compare |
| v4 | 2022-02-25 | English | Compare |
| v3 | 2022-02-18 | English | Compare |
| v2 | 2022-02-17 | French | Compare |
| v1 | 2022-02-17 | English | Compare |
Showing 1 to 8 of 8